PubMed Health⌕ Search

Biomedical subjects

J Mathur

Publications and source records attributed to J Mathur.

24 records · Page 2Linked to original sources
PubMed1996

Brassinosteroids rescue the deficiency of CYP90, a cytochrome P450, controlling cell elongation and de-etiolation in Arabidopsis.

The cpd mutation localized by T-DNA tagging on Arabidopsis chromosome 5-14.3 inhibits cell elongation controlled by the ecdysone-like brassinosteroid hormone brassinolide. The cpd mutant displays de-etiolation and derepression of light-induced genes in the dark, as well as dwarfism, male sterility, and activation of stress-regulated genes in the light. The CPD gene encodes a cytochrome P450 (CYP90) sharing homologous domains with steroid hydroxylases. The phenotype of the cpd mutant is restored to wild type both by feeding with C23-hydroxylated brassinolide precursors and by ectopic overexpression of the CPD cDNA. Brassinosteroids also compensate for different cell elongation defects of Arabidopsis det, cop, fus, and axr2 mutants, indicating that these steroids play an essential role in the regulation of plant development.

Arabidopsis↗
PubMed1995

Dose characteristics of a new 300kVp orthovoltage machine.

The dose characteristics of a relatively new type of orthovoltage machine which displays different beam qualities compared to other orthovoltage machines has been studied. Surface dose, depth dose and dose profiles have been measured with various ionization chambers as well as diodes and thermoluminescent dosemeters. Profiles produced by the 300kVp x-ray machine's fixed and variable collimators show no significant differences. A slight depth dose build up effect of 2% is seen over the first 1mm with the variable collimator at 250kVp but this is not seen with the fixed collimators. Surface charge is increased to 110%, normalised to 100% at 0.3mm depth in solid water when the front perspex plate of the 10x10cm 50cm FSD fixed collimator is removed. The use of a magnetic field placed directly under the fixed collimator to sweep away any electrons produced has shown that the extra charge and thus dose is caused mainly by electrons produced from the fixed collimator material. The percentage surface charge was reduced from 110% to 102% at 50cm FSD with the magnetic field energised.

Electrons↗
PubMed1994

Surface doses from combined electron/photon fields in a radiotherapy.

Using mixed modality treatments of photon and electron beams, some skin sparing can be acquired whilst administering a safer dose to crucial structures such as the spine or lung. The combination of 6MV X-rays and 12MeV electron beams in the treatment of breast nodes is a clinical example where such treatments are beneficial. By weighting the photon and electron beams accordingly, the surface dose and dose at depth can be changed whilst not dramatically varying the depth at which the 90% dose level is maintained. In order to accurately predict near surface dose, build up results were obtained using TLD extrapolation, Markus parallel plate and Attix parallel plate ionisation chambers in a solid water phantom. This data was then used to predict surface dose due to different beam weights. Depending on the weightings given to the photon and electron beams, the surface dose and dose at depth varies. For example, when 6MV X-rays and 12MeV electrons are combined the percentage dose at surface and 20cm depth is 46%/23%, 54%/20%, 61%/15% for 60/40, 50/50 and 40/60 X-ray/electron weightings respectively. For these weightings, the depth of the 90% level remained at 30mm. From a clinical point of view this data is important, showing that the 90% level of radiation does not vary in depth significantly provided the ratio of photon/electron weights is kept within a range of 60/40 to 40/60. However by varying the weightings, the ability to control dose to skin in particular to produce the optimum level for both areas whilst still delivering the required tumour dose is obtained.

Electrons↗
PubMedDate not supplied

Social support effects on cardiovascular reactivity: is a stranger as effective as a friend?

OBJECTIVE: We investigated whether the effects on cardiovascular reactivity of social support from an audience member depend only on the behavior of that person or also depend on the relationship between the audience and the actor. That is, is there any added reduction in physiological response if the person who is nodding and smiling supportively is also a friend? METHOD: Ninety subjects gave a speech to an observer. In two of the conditions, this observer was a confederate of the experimenter and a stranger to the subject. This confederate acted in either a supportive or neutral manner during the speech. In the final condition, this observer was a friend, brought by the subject, who was then trained to show support in the same manner as the supportive confederate. The comparison of the two confederate conditions tested the effect of support, holding the relationship constant. The comparison of friend and confederate supportive conditions tested the effect of the relationship, holding the supportive behaviors constant. All participants were female. RESULTS: Both supportive conditions produced significantly smaller cardiovascular increases than the confederate-neutral condition, and the friend-supportive condition produced significantly smaller systolic blood pressure increases than the confederate-supportive (friend-supportive: 7.9 mm Hg: confederate-supportive: 14.9 mm Hg; confederate-neutral: 22.9 mm Hg). Differences for diastolic pressure and heart rate were not significant, although the data followed the same pattern. CONCLUSIONS: Social support from a friend attenuated cardiovascular reactivity in a laboratory setting to a greater degree than support from a stranger. The subjects' construal of the supportive behaviors can have an effect on reactivity, over and above the effects of the actual behaviors themselves.

Adolescent↗